New data for Tezspire and Breztri demonstrate AstraZeneca’s innovation and commitment to transform care in COPD
Liraglutide is a drug-device combination formulation used in the treatment of Type 2 Diabetes Mellitus
US FDA approval based on NEURO-TTRansform Phase III results
Development services for gene and cell therapies is planned to begin first in 2025
Announces changes in the commercial organization to incorporate Seagen and improve focus, speed and execution
STABILIZE-CKD and DIALIZE-Outcomes trials are part of the CRYSTALIZE evidence programme
Approval of oral, once-daily VELSIPITY based on favorable safety and efficacy data from the ELEVATE UC Phase 3 trials
Bains has stepped down from his role on the Biocon Board as an Independent Director with immediate effect
The Government of India continues to prioritise initiatives aimed at enhancing the accessibility and equity of health services
The biopharmaceutical leader shared its expert perspective at the Equality Lounge at the G20 Summit
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)